Latest News - Biotech - United States - North Carolina

South-Tek Systems has been awarded a new contract to supply Nitrogen Generators for a 600 MW (nominal) 2 X 1 Combined Cycle Power Plant at an existing Energy Complex of a major Utility Company.

Trana Discovery and Southern Research Institute today announced that several bioactive hits from a set of 15,000 diverse small molecule compounds screened under contract with the NIAID exhibit antiviral activity against HIV-1 infected cells.

Richard Martin, CFO of Entegrion, joined forty-four distinguished professionals as Triangle Business Leader and BDO Seidman LLP’s 2009 Top CFOs of the Triangle.

Noesys Data is focused on providing tools to reduce the time from data to knowledge, maximize information gained within each experiment, and improve research decision-making within the Safety Pharmacology, Infectious Disease, and Biodefense fields.

Entegrion, Inc., a privately owned life sciences product development company specializing in technologies for hemorrhage control, resuscitation, and tissue repair, was a winner in the 2009 New Product & Technology Awards.

Biotech Vendor Services, Inc. (BVS) is pleased to announce that our much anticipated “La Jolla Drug Development Day” will take place on Wednesday, July 22 at the Hyatt Regency Hotel in La Jolla, California.

New advisory board to identify assay development opportunities for emerging and drug-resistant infectious diseases…

An article co-authored by Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, has been selected for the 2008 Jack L. Beal Award.

Michael Jenkins, PhD, general manager of Catalent’s Middleton, WI facility, will present at the BIO Process Theatre of the 2009 BIO International Convention. His talk will focus on Catalent’s GPEx technology for mammalian cell line engineering.

Two Catalent scientists, Dr. Tom Feinberg, director of structural chemistry services, and Dr. Craig Davies-Cutting, director of research and development, will host a 45-minute interactive workshop at RDD Europe 2009.

Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, will present this month at the TIDES 2009 Conference to be held in Las Vegas, NV, May 17-20, 2009.

Agency Develops Logo and Packaging for New Product

Drug discovery technology company develops tools to find new treatments for serious infectious diseases…

An article written by Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, was featured in the Biotechnology Industry Organization’s (BIO) March 2009 e-Newsletter and is available for download @ www.bio.org.

Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be teaching a course titled "Bioassay Method Development and Validation" on April 2-3 in San Francisco for IBC Life Sciences.

Michael Barron, MBA, Account Director at Catalent Pharma Solutions, will be a presenter at The Center for Business Intelligence’s (CBI) 2nd Annual Conference on Comparator Studies on March 26-27, 2009 in Philadelphia, P.A.

Regional Capital Forum Selects RTP Biotech Company To Present

Brand Counsel, LLC, a brand strategy consulting firm, today announced the launch of a new brand assessment tool, called BrandScope, which helps companies evaluate the current value and relevancy of their corporate and product branding strategies.

Catalent Pharma Solutions, a worldwide leading provider of advanced technologies for pharmaceutical, biotechnology and consumer health companies, will be featured in the upcoming April edition of Journal of Pharmaceutical Research.

MDS Nordion event information, Society of Interventional Radiology 2009 Scientific Meeting, San Diego, CA

MDS Nordion on-site event information for Society of Interventional Radiology 2009 scientific meeting, San Diego, CA

Dr. Peter Johnson has joined life sciences company Entegrion as the new Executive Vice President and Chief Business Officer.

Two members of Catalent's Respiratory, Analytical and Biotechnology Group will participate in the Parenteral Drug Association West Coast Chapter’s panel discussion titled “Challenges and Best Practices in Extractable and Leachables.”

Dr. Greg Bleck, the senior director of cell line engineering at Catalent Pharma Solutions, will present at the 12th Annual Pep Talk 2009 Protein Expression Conference to be held in San Diego, C.A., January 12-14, 2009.

Product Life-Cycle Signal Management Can Help Pharmaceutical Companies Protect Public Health and Product Assets

Greg Bleck, the senior director of cell line engineering at Catalent Pharma Solutions, will present this week at the 2nd International Cell Engineering Conference to be held in Santa Barbara, C.A., December 2-4, 2008.

Catalent’s Respiratory, Analytical and Biotechnology Group will be well represented at this year’s American Association of Pharmaceutical Scientists Annual Meeting with a number of its team members conducting scientific poster presentations.

RTP-based Entegrion, which is developing blood coagulation and related technologies, is launching commercial sales of its Stasilon wound dressings that are designed to stop blood loss.

Entegrion, a Research Triangle Park-based company, has been awarded a contract with the Department of the Navy to develop an integrated dried plasma packaging and administration system for treating severely wounded patients under extreme conditions.

Both presedential candidates, Barack Obama and John McCain, agree that new technology should be used in the fight against biological warfare. QualSec, developers of the NanoNose, can provide an answer to national bio-threats.

Life sciences company Entegrion will exhibit at the annual Advanced Technology Applications for Combat Casualty Care (ATACCC) Conference in Florida this week.

Life sciences company Entegrion continues to strengthen its leadership team with the addition of Michael Galiger, its new manufacturing and engineering manager. Galiger has more than 10 years of experience in medical and consumer products industries.

In a partnership with LC Industries of Durham, N.C., life sciences company Entegrion is now selling its FDA approved Stasilon™ - FR wound dressings in LC Industries-operated military base supply centers across the country.

InfoStrength today announced that James Farley, President of Cardinal Consulting and Training, has joined InfoStrength in an advisory role.

PDA uses InfoStrength Smart Enterprise Suite to increase collaboration among its members worldwide.

– InfoStrength launches its new Life Science regulatory software solutions website.

“Tim’s level of high quality customer service and proven track record is an excellent fit for the continued growth of the InfoStrength® Smart Enterprise Suite,” said Russ King, Vice President of Business Development at InfoStrength

Evangelia Evdaimon was elected to her third term as Chair of the Issues and Methods Committee for the North Carolina Chapter of The Society of Quality Assurance

InfoStrength ends the year with Outstanding customer service survey results.

Intelliject, a Medical Device company, expanded the use of the InfoStrength Smart Enterprise Suite for due diligence business processes

CivaTech Oncology, Inc. uses InfoStrength's Smart Enterprise Suite to establish policies for regulatory, quality and corporate documents in preparation of ISO 13485 and FDA 510k.

ThotWave Technologies has announced that Greg Nelson, President and CEO of ThotWave, has been named as Channel Manager for the Business Intelligence Network.